Company: ANIX
Filing Date: 2025-03-11
Form Type: 10-Q
Source: 0001493152-25-009854
Chunk: 10

Company: Anixa Biosciences Inc
Filing Date: 2025-03-11
Form: 10-Q
Item: Part I, Item 8
Chunk 10
---
ANDING AND EXERCISABLE

    Range of 
Exercise Prices

    Number 
Outstanding and 
Exercisable

    Weighted Average 
Remaining 
Contractual Life 
(in years)

    Weighted 
Average 
Exercise Price

    $
    0.67 - $2.27

    316,000

    2.5

    $
    1.11

    $
    2.58 - $3.13

    251,968

    1.1

    $
    2.93

    $
    3.46 - $5.30

    419,000

    3.2

    $
    3.93

2018 Share Plan

The 2018 Share Plan provides for
the grant of incentive stock options, nonqualified stock options, stock appreciation rights, stock awards, performance awards and stock
units to employees, directors and consultants. As of January 31, 2025, the 2018 Share Plan had 645,000 shares available for future grants.
Information regarding the 2018 Share Plan for the three months ended January 31, 2025 is as follows:

 SCHEDULE
OF OPTION ACTIVITY

    Shares

    Weighted 
Average Exercise 
Price Per Share

    Aggregate
    Intrinsic Value
    (in thousands)

    Options outstanding at October 31, 2024

    11,171,094

    $
    3.74

    Granted

    1,355,000

    2.37

    Forfeited/expired

    (25,000
    )

    3.96

    Options outstanding at January 31, 2025

    12,501,094

    $
    3.59

    $
    1,093

    Options exercisable at January 31, 2025

    8,260,549

    $
    3.56

    $
    391

     10 

The following table summarizes
information about stock options outstanding and exercisable under the 2018 Share Plan as of January 31, 2025:

 SCHEDULE
OF OPTIONS OUTSTANDING AND EXERCISABLE

    Options Outstanding

    Options Exercisable

    Range of 
Exercise Prices

    Number 
Outstanding

    Weighted 
Average 
Remaining 
Contractual Life 
(in years)

    Weighted 
Average 
Exercise